Skip to main content
. 2017 Aug 9;12(8):e0182804. doi: 10.1371/journal.pone.0182804

Fig 1. Recombinant Aβ42 is more cytotoxic than synthetic Aβ42.

Fig 1

MTT survival assay after 24h of peptide treatment at indicated concentrations. Averages from two experiments and six replicates. Error bars represent SEM. A pairwise T-test across all dose series gave a p = 0.004 comparing the synthetic (SYN) and recombinant (REC), a p = 0.001 comparting REC and vehicle (VEH), and a p = 0.06 comparing SYN to VEH.